epicyte

ep·i·cyte

(ep'i-sīt),
A cell membrane, especially of protozoa; the external layer of cytoplasm in gregarines.
[epi- + G. kytos, cell]

epicyte

/epi·cyte/ (ep´ĭ-sīt) cell membrane.

ep·i·cyte

(ep'i-sīt)
A cell membrane, especially of protozoa; the external layer of cytoplasm in gregarines.
[epi- + G. kytos, cell]

epicyte

cell membrane.
References in periodicals archive ?
It was issued to The Scripps Research Institute, where the technology was developed, and exclusively licensed to Epicyte Pharmaceutical which was acquired by Biolex in 2004.
The production of pharmaceuticals from plants has been targeted by a number of large companies, including Monsanto and Syngenta, as well as small companies such as Epicyte, Ventria BioSciences and Meristem Therapeutics.
Epicyte plans to use its plant-based antibody manufacturing technology to produce the C.
El 9 de enero de 2001, la compania biotecnologica Epicyte (San Diego, Estados Unidos), socio corporativo de la multinacional Dow Chemicals, declaro al diario ingles The Observater: "Tenemos un invernaculo lleno de plantas de maiz que estan produciendo anticuerpos espermicidas .
Dow also has agreement with Epicyte Pharmaceutical for the development of monoclonal antibodies in transgenic plants.
A genetically engineered "contraceptive corn" has been developed by Epicyte, a company in San Diego, California.
The antibody DNA is "coded" into the crop, according to San Diego biotech firm Epicyte.
The San Diego-based EPIcyte has partnered with Dow Chemical to develop and produce experimental human antibodies in plants, as well as a topical contraceptive and a microbicide that is purported to be active against HIV.
Whaley and Larry Zeitlin of Epicyte Pharmaceuticals in San Diego, also in the October NATURE BIOTECHNOLOGY.
Epicyte will use this technology to produce its antibody pipeline and to address capacity constraints in the antibody-based therapeutics market which is estimated to reach $8 billion by 2004.